--(BUSINESS WIRE)----Merck & Co., Inc. will host a conference call for pharmaceutical and business journalists and analysts to discuss the preliminary analyses of the off-drug extension of the APPROVe study of VIOXX.
WHO:Peter S. Kim, Ph.D., president, Merck Research Laboratories Kenneth C. Frazier, senior vice president and general counsel, Merck
WHEN: Thursday, May 11, 2006, 4:30 p.m. ET DIAL-IN: In the United States, dial (866) 202-1971/ Passcode: 11833956
Outside of the United States, dial (617) 213-8842/ Passcode: 11833956 REPLAY: A replay of this call will be available from 5 p.m. ET, May 11 until 11:59 p.m. ET, May 25.
In the United States, dial (888) 286-8010/ Passcode: 73501895
Outside of the United States, dial (617) 801-6888/ Passcode: 73501895
WEBCAST: A live audio Web cast will be available at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c= 190190&eventID=1317899
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser’s URL address field.)
Contact: Merck & Co., Inc. Media: Jeanine Clemente, 908-423-6308 Associate Manager, Public Affairs or Investor: Graeme Bell, 908-423-5185 Senior Director, Investor Relations
Source: Merck & Co., Inc.
